166 related articles for article (PubMed ID: 37887947)
1. pH-Sensitive Nanoparticles for Colonic Delivery Anti-miR-301a in Mouse Models of Inflammatory Bowel Diseases.
Wang J; Yao M; Zou J; Ding W; Sun M; Zhuge Y; Gao F
Nanomaterials (Basel); 2023 Oct; 13(20):. PubMed ID: 37887947
[TBL] [Abstract][Full Text] [Related]
2. Colon-specific delivery of methotrexate using hyaluronic acid modified pH-responsive nanocarrier for the therapy of colitis in mice.
Lv Y; Ren M; Yao M; Zou J; Fang S; Wang Y; Lan M; Zhao Y; Gao F
Int J Pharm; 2023 Mar; 635():122741. PubMed ID: 36804523
[TBL] [Abstract][Full Text] [Related]
3. Garcinol Encapsulated Ph-Sensitive Biodegradable Nanoparticles: A Novel Therapeutic Strategy for the Treatment of Inflammatory Bowel Disease.
Jacob EM; Borah A; Pillai SC; Kumar DS
Polymers (Basel); 2021 Mar; 13(6):. PubMed ID: 33799680
[TBL] [Abstract][Full Text] [Related]
4. Colon-targeted delivery of tacrolimus using pH-responsive polymeric nanoparticles for murine colitis therapy.
Cai X; Wang X; He M; Wang Y; Lan M; Zhao Y; Gao F
Int J Pharm; 2021 Sep; 606():120836. PubMed ID: 34217824
[TBL] [Abstract][Full Text] [Related]
5. XA pH-Responsive and Colitis-Targeted Nanoparticle Loaded with Shikonin for the Oral Treatment of Inflammatory Bowel Disease in Mice.
Feng J; Wang Y; Lv Y; Fang S; Ren M; Yao M; Lan M; Zhao Y; Gao F
Mol Pharm; 2022 Nov; 19(11):4157-4170. PubMed ID: 36106774
[TBL] [Abstract][Full Text] [Related]
6. Targeted delivery of budesonide in acetic acid induced colitis: impact on miR-21 and E-cadherin expression.
Seoudi SS; Allam EA; El-Kamel AH; Elkafrawy H; El-Moslemany RM
Drug Deliv Transl Res; 2023 Nov; 13(11):2930-2947. PubMed ID: 37184747
[TBL] [Abstract][Full Text] [Related]
7. Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease.
Shrestha N; Xu Y; Prévost JRC; McCartney F; Brayden D; Frédérick R; Beloqui A; Préat V
Acta Biomater; 2022 Mar; 140():561-572. PubMed ID: 34923097
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of pH-sensitive nanoparticles of budesonide for the treatment of ulcerative colitis.
Zhou H; Qian H
Drug Des Devel Ther; 2018; 12():2601-2609. PubMed ID: 30174414
[TBL] [Abstract][Full Text] [Related]
9. Orally administered docetaxel-loaded chitosan-decorated cationic PLGA nanoparticles for intestinal tumors: formulation, comprehensive in vitro characterization, and release kinetics.
Ünal S; Doğan O; Aktaş Y
Beilstein J Nanotechnol; 2022; 13():1393-1407. PubMed ID: 36483636
[TBL] [Abstract][Full Text] [Related]
10. pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease.
Beloqui A; Coco R; Memvanga PB; Ucakar B; des Rieux A; Préat V
Int J Pharm; 2014 Oct; 473(1-2):203-12. PubMed ID: 25014369
[TBL] [Abstract][Full Text] [Related]
11. Colon-targeted delivery of cyclosporine A using dual-functional Eudragit
Naeem M; Bae J; Oshi MA; Kim MS; Moon HR; Lee BL; Im E; Jung Y; Yoo JW
Int J Nanomedicine; 2018; 13():1225-1240. PubMed ID: 29535519
[TBL] [Abstract][Full Text] [Related]
12. Oral targeted delivery of Imatinib by pH responsive copolymer modulates liver fibrosis in the mice model.
Siapoush S; Mousazadeh H; Rezaei R; Hatami B; Mazhari S; Hashemi N; Reza Zali M; Baghaei K
Int J Pharm; 2023 Jun; 641():123068. PubMed ID: 37225027
[TBL] [Abstract][Full Text] [Related]
13. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound.
Wang J; Wang F; Li X; Zhou Y; Wang H; Zhang Y
Colloids Surf B Biointerfaces; 2019 May; 177():425-432. PubMed ID: 30798063
[TBL] [Abstract][Full Text] [Related]
14. Glycyrrhizic acid-loaded pH-sensitive poly-(lactic-co-glycolic acid) nanoparticles for the amelioration of inflammatory bowel disease.
Zeeshan M; Ali H; Khan S; Mukhtar M; Khan MI; Arshad M
Nanomedicine (Lond); 2019 Aug; 14(15):1945-1969. PubMed ID: 31355705
[No Abstract] [Full Text] [Related]
15. Polyketal Nanoparticles Co-Loaded With miR-124 and Ketoprofen for Treatment of Rheumatoid Arthritis.
Zhao M; Yao J; Meng X; Cui Y; Zhu T; Sun F; Li Y; Teng L
J Pharm Sci; 2021 May; 110(5):2233-2240. PubMed ID: 33516754
[TBL] [Abstract][Full Text] [Related]
16. Design and in vitro characterization of multistage silicon-PLGA budesonide particles for inflammatory bowel disease.
Leonard F; Srinivasan S; Liu X; Collnot EM; Ferrari M; Lehr CM; Godin B
Eur J Pharm Biopharm; 2020 Jun; 151():61-72. PubMed ID: 32283213
[TBL] [Abstract][Full Text] [Related]
17. Colitis-targeted hybrid nanoparticles-in-microparticles system for the treatment of ulcerative colitis.
Naeem M; Lee J; Oshi MA; Cao J; Hlaing SP; Im E; Jung Y; Yoo JW
Acta Biomater; 2020 Oct; 116():368-382. PubMed ID: 32937207
[TBL] [Abstract][Full Text] [Related]
18. Development, Characterization, and Investigation of In Vivo Targeted Delivery Efficacy of Luteolin-Loaded, Eudragit S100-Coated mPEG-PLGA Nanoparticles.
Liu X; Zhang M; Tian Y; Liu R; Wang Y; Guo F; Gong Y; Yan M
AAPS PharmSciTech; 2022 Mar; 23(4):100. PubMed ID: 35348949
[TBL] [Abstract][Full Text] [Related]
19. Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseases.
Ali H; Weigmann B; Neurath MF; Collnot EM; Windbergs M; Lehr CM
J Control Release; 2014 Jun; 183():167-77. PubMed ID: 24685705
[TBL] [Abstract][Full Text] [Related]
20. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]